William S. Lawrence
Affiliations: | 2010 | University of Texas Medical Branch, Galveston, TX |
Google:
"William Lawrence"Parents
Sign in to add mentor| Johnny W. Peterson | grad student | 2010 | UTMB | |
| (Pathophysiology of inhalational anthrax.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Prasad AN, Fenton KA, Agans KN, et al. (2023) Pathogenesis of aerosolized Ebola virus variant Makona in nonhuman primates. The Journal of Infectious Diseases |
| Martchenko Shilman M, Bartolo G, Alameh S, et al. (2021) Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax. Acs Infectious Diseases |
| Lawrence WS, Peel JE, Sivasubramani SK, et al. (2020) Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model. Pathogens (Basel, Switzerland). 9 |
| Yu L, Peel G, Cheema F, et al. (2020) Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system Materials Today Physics. 15: 100249 |
| Prasad AN, Agans KN, Sivasubramani SK, et al. (2019) A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys. The Journal of Infectious Diseases |
| Rossi SL, Comer JE, Wang E, et al. (2019) Immunogenicity and Efficacy of a Measles Virus-vectored Chikungunya Vaccine in Nonhuman Primates. The Journal of Infectious Diseases |
| Tao P, Mahalingam M, Zhu J, et al. (2018) A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague. Mbio. 9 |
| Escaffre O, Hill T, Ikegami T, et al. (2018) Experimental Infection of Syrian Hamsters with Aerosolized Nipah virus. The Journal of Infectious Diseases |
| Sim BKL, Li M, Osorio M, et al. (2017) Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis. Npj Vaccines. 2: 17 |
| Sha J, Kirtley ML, Klages C, et al. (2016) A replication-defective human type-5 adenovirus-based trivalent vaccine confers complete protection against plague in mice and non-human primates. Clinical and Vaccine Immunology : Cvi |